PHS
PFM Health Sciences Portfolio holdings
AUM
$1.15B
This Quarter Return
+6.54%
1 Year Return
+21.39%
3 Year Return
+130.75%
5 Year Return
+265.32%
10 Year Return
+1,236.5%
AUM
$3.11B
AUM Growth
+$3.11B
(+8.3%)
Cap. Flow
+$91.8M
Cap. Flow
% of AUM
2.96%
Top 10 Holdings %
Top 10 Hldgs %
37.14%
Holding
93
New
12
Increased
19
Reduced
13
Closed
9
Top Buys
| 1 |
SGEN
Seagen Inc. Common Stock
SGEN
|
$76.3M |
| 2 |
Centene
CNC
|
$37.3M |
| 3 |
Acadia Pharmaceuticals
ACAD
|
$36.7M |
| 4 |
ARNA
Arena Pharmaceuticals Inc
ARNA
|
$23.6M |
| 5 |
Guardant Health
GH
|
$21.1M |
Top Sells
| 1 |
PPD
PPD, Inc. Common Stock
PPD
|
$41.5M |
| 2 |
AstraZeneca
AZN
|
$36M |
| 3 |
Insulet
PODD
|
$30.9M |
| 4 |
ALXN
Alexion Pharmaceuticals Inc
ALXN
|
$29.1M |
| 5 |
Gilead Sciences
GILD
|
$28.1M |
Sector Composition
| 1 | Healthcare | 94.1% |
| 2 | Financials | 0.31% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
76
iShares Biotechnology ETF
IBB
$5.6B
| – | – | 0 | – | – |
|
77
iTeos Therapeutics
ITOS
$449M
| – | – | -232,216 | Closed | -$7.94M |
|
78
Madrigal Pharmaceuticals
MDGL
$9.76B
| – | – | -82,534 | Closed | -$9.65M |
|
79
Moderna
MRNA
$9.37B
| – | – | 0 | – | – |
|
|
80
Insulet
PODD
$23.9B
| – | – | -118,382 | Closed | -$30.9M |
|
81
Terns Pharmaceuticals
TERN
$609M
| – | – | -329,274 | Closed | -$7.24M |
|
82
Vertex Pharmaceuticals
VRTX
$100B
| – | – | -46,889 | Closed | -$10.1M |
|
83
SPDR S&P Biotech ETF
XBI
$5.07B
| – | – | 0 | – | – |
|
84
Health Care Select Sector SPDR Fund
XLV
$33.9B
| – | – | 0 | – | – |
|
|
SPRB
85
DELISTED
Spruce Biosciences, Inc. Common Stock
SPRB
| – | – | -489,631 | Closed | -$8.13M |
|
|
CERN
86
DELISTED
Cerner Corp
CERN
| – | – | -139,569 | Closed | -$10M |
|
|
PPD
87
DELISTED
PPD, Inc. Common Stock
PPD
| – | – | -1,096,492 | Closed | -$41.5M |
|